Provider of intellectual property, scientific and academic research information, analytics and software services.
Provider of intellectual property, scientific and academic research information, analytics and software services.
Earns most of its income from annual subscriptions to databases and software that customers use every day, so revenue is recurring and tied to renewal rates; trademark and patent filing services add transaction-based income. It was carved out of Thomson Reuters in 2016 and has grown by acquisition.
Moat: narrow (data, switching costs, brand). Proprietary, decades-deep IP and citation databases are difficult and costly for rivals to replicate.
Headquarters: London, United Kingdom · Founded: 2016 · Employees: 12,000
Size Clarivate (CLVT) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $1.38B, the 2026th largest of 3,085 United States companies the cockpit tracks. Shares closed at $2.16 on 18 Nov 2026.
Performance Over six months the shares fell 12.2%, against -17.4% for the median peer and -2.2% for the United States market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue fell 9.2% over the last twelve months (peer median +8.9%); the operating margin is 7.9% (peer median 7.1%).
Valuation It trades at 3.5× forward earnings against a peer median of 21.2× (cheapest of 17).
Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -1 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.5 points below its cost of capital (7.2% WACC).
Short interest Short interest is 7.6% of the free float (30 Oct 2026).
Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.27B | $2.46B | $2.56B | $2.63B | $2.66B |
| Revenue growth | — | -4% | -3% | -1% | — |
| Gross profit | $829M | $864M | $960M | $1.01B | $995M |
| EBITDA | $901M | $936M | $960M | $983M | $976M |
| Net income | -$386M | -$201M | -$637M | -$911M | -$3.96B |
| Free cash flow | $322M | $365M | $337M | $502M | $304M |
| Capital expenditure | $237M | $263M | $289M | $242M | $203M |
| Total debt | $4.18B | $4.48B | $4.59B | $4.81B | $5.10B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Clarivate CLVT | $1.38B | -12% | -9% | 8% | 3.5× | 13.2% |
| Relx REL.L | $67.6B | +21% | +2% | 32% | 20.9× | 1.7% |
| Thomson Reuters TRI.TO | $45.0B | +27% | +6% | 26% | 23.7× | 2.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CLVT | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +21.4% | -2.3% | 3rd highest of 21 |
| 6-month return | -12.2% | -17.4% | 9th highest of 21 |
| Distance from 52-week high | -44.2% | -35.4% | 8th lowest of 21 |
| Revenue growth (TTM) | -9.2% | +8.9% | 3rd lowest of 21 |
| Operating margin | 7.9% | 7.1% | 10th highest of 21 |
| Forward P/E | 3.5× | 21.2× | cheapest of 17 |
| Growth the price implies (Req g, 7 yrs) | 13.2% | 6.6% | 6th most demanding of 16 |
| Growth delivered (Del g) | +14.4% | +8.1% | 4th highest of 16 |
| Hurdle (Req g minus delivered) | -1.1 pp | -4.5 pp | 7th most demanding of 16 |
| ROIC minus cost of capital | -5.5 pp | +0.7 pp | 6th lowest of 20 |
| EV / EBITDA | 5.9× | 8.4× | 2nd cheapest of 9 |
| Net debt / EBITDA | 4.4× | 1.9× | most indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Clarivate CLVT | United States | $1.38B | -12% | -9% | 8% | 3.5× | 13.2% | +14.4% |
| Central Mine Planning & Design Institute CMPDI.NS | India | $1.38B | -22% | +10% | 33% | n/a | 4.5% | +18.7% |
| Shanghai Medicilon 688202.SS | China | $1.39B | +8% | +42% | -2% | 85.1× | n/a | n/a |
| Shenzhen Ampron Technology 301413.SZ | China | $1.40B | -28% | +11% | 2% | 387.2× | n/a | n/a |
| Offcn Education Technology 002607.SZ | China | $1.40B | -40% | -2% | 13% | 34.7× | 15.7% | -27.6% |
| Derichebourg DBG.PA | France | $1.37B | -18% | -3% | 5% | 8.8× | 6.7% | +6.3% |
| ICF International ICFI | United States | $1.40B | +14% | -5% | 8% | 10.4× | -2.5% | +4.4% |
| PharmaBlock Sciences (Nanjing) 300725.SZ | China | $1.36B | +5% | +11% | 11% | 37.5× | 24.2% | +14.1% |
| CRA International CRAI | United States | $1.35B | +46% | +13% | 10% | 23.3× | 6.6% | +8.1% |
| SBS 2384.T | Japan | $1.35B | +26% | +17% | 5% | 13.9× | -4.7% | +13.8% |
| AFRY AFRY.ST | Sweden | $1.42B | +5% | -4% | 7% | 12.5× | -2.2% | +6.3% |
| China National Electric Apparatus Research Institute 688128.SS | China | $1.35B | -17% | +8% | 11% | 14.7× | 3.2% | +13.5% |
| Yangzhou Tinfulong 603406.SS | China | $1.42B | -29% | -4% | 12% | n/a | 6.1% | +10.6% |
| China Security 600654.SS | China | $1.34B | -31% | -30% | -1% | n/a | 56.0% | +0.4% |
| Shanghai Foreign Service 600662.SS | China | $1.42B | -14% | +1% | 2% | 13.2× | n/a | n/a |
| Changchun Up Optotech 002338.SZ | China | $1.34B | -41% | +22% | 2% | 43.1× | n/a | n/a |
| Moltiply MOL.MI | Italy | $1.45B | +12% | +20% | 16% | 14.0× | 10.9% | +21.0% |
| TKC 9746.T | Japan | $1.31B | +22% | +5% | 20% | 19.1× | -10.1% | +5.7% |
| Visual China 000681.SZ | China | $1.46B | -34% | -9% | 4% | 37.6× | 57.8% | +6.5% |
| Shanghai MicroPort EP Medtech 688351.SS | China | $1.31B | -30% | +20% | 3% | 137.1× | 42.5% | +26.7% |
| Guangdong Feinan Resources Recycling 301500.SZ | China | $1.49B | -38% | +42% | 7% | n/a | n/a | n/a |